Palmitoyl dipeptide-7 was found to enhance differentiation of the epidermis, basement membrane zone,and dermal fibroblasts.
CAT No: 10-101-222
CAS No:911813-90-6
Synonyms/Alias:Palmitoyl dipeptide-7;palmitoyl lysylthreonine;911813-90-6;PAL-KT;Palmitoyl-lysine-threonine;UNII-JHF843U5C5;JHF843U5C5;PALMITOYL-LYS-THR;L-Threonine, N2-(1-oxohexadecyl)-L-lysyl-;DTXSID10238438;N2-(1-Oxohexadecyl)-L-lysyl-L-threonine;(2S,3R)-2-[[(2S)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoic acid;palmitoyl-L-lysyl-L-threonine;SCHEMBL1032838;Palmitoyl Dipeptide-7 palestrina;DTXCID30160929;HY-P5267;PALMITOYL DIPEPTIDE-7 [INCI];DA-76563;CS-0863913;Q27281511;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.